Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Sci/Tech
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Education 
Sport 
Entertainment 
Talking Point 
In Depth 
AudioVideo 
Wednesday, 1 March, 2000, 09:33 GMT
Plants produce human protein
BBC
Tobacco is commonly used in plant research
Scientists have developed a new way of getting plants to make a human protein.

Researchers at the biotech company Monsanto engineered tobacco to express human somatotropin (hST), a hormone most often used to treat hypopituitary dwarfism in children.

The gene coding for the protein was introduced into the chloroplasts, the small compartments in leaf cells that generate energy from sunlight. This is a first for genetic modification (GM).

Until now, most GM work has focused on introducing foreign genes into nuclear DNA, not the small amount of DNA that is located outside the nucleus in the chloroplasts.

Gene containment

The ease of growing plants means the new route promises a high-yield, relatively low-cost alternative to the manufacture of pharmaceuticals using traditional GM technology such as in modified bacteria.

Interestingly, chloroplast DNA is not transferred through pollen. This means that crossing the modified plants with wild-type tobacco would result in offspring that contained no foreign genes within their nuclear or chloroplast DNA.

This may be a way of preventing genetic modifications from "leaking" into the environment, a major concern of environmental groups.

However, the Monsanto team claim that this issue, although worthy of note, was not the focus of the research. Their main aim was simply to produce as much of the protein as possible in the tobacco leaves, and the chloroplast technique resulted in a 300-fold increase in yield over that achieved using nuclear modifications.

Critical difference

"We tried to produce the protein in the nuclear compartment but we were only able to produce very low levels," Dr Jeffrey Staub, leader of the Monsanto research team, told BBC News Online. "The chloroplast genetic system was able to produce a high level of the protein.

"Truthfully, we don't know what the critical difference is at this time. This is not to say that chloroplasts would be better for every protein - it is just to say that in this case, they were better for the human somatotropin."

Monsanto plan to extend the research which is published in the journal Nature Biotechnology. It was a small scale study and far more work will be needed to fully exploit the potential of chloroplast genetics.

"By introducing genes into the chloroplasts, which are the sites of many metabolic pathways, we may be able to produce larger amounts of metabolic end products - such as vitamins, which may be used to enhance the nutritional value of foods," Dr Staub said.

"Another possibility might be to have better seed-specific accumulation of other important nutritional components like proteins and oils. And of course, there is the possibility of over-producing pharmaceutical proteins."

Search BBC News Online

Advanced search options
Launch console
BBC RADIO NEWS
BBC ONE TV NEWS
WORLD NEWS SUMMARY
PROGRAMMES GUIDE
See also:

25 Feb 00 |  Sci/Tech
GM firms fund friendly scientists
28 Sep 99 |  Sci/Tech
Scientists unveil plastic plants
27 Jul 99 |  Sci/Tech
GM tree is more 'green'
20 May 99 |  Sci/Tech
GM pollen 'can kill butterflies'
13 Jan 00 |  Sci/Tech
Yellow rice gives dietary boost
Internet links:


The BBC is not responsible for the content of external internet sites

Links to other Sci/Tech stories are at the foot of the page.


E-mail this story to a friend

Links to more Sci/Tech stories